Trial intelligence / Profile preview

AMEED for Corneal Epithelium Healing

NCT02746848Phase 2Completed

Sponsor
Royan Institute
Start
Jun 2014
Primary completion
May 2015
Modality
Recombinant Proteins and Enzymes
01

Overview

A Phase 2 trial of Amniotic membrane extract eye drops in corneal injury, sponsored by Royan Institute. Started Jun 2014; status: completed.

02

Drugs

Amniotic membrane extract eye drops
03

Conditions

corneal injury

Beyond the preview

Go deeper on NCT02746848.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02746848.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call